Insider Trading & Ownership - Sebelius Kathleen

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Sebelius Kathleen
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-04-08
Purchase
2025-04-08
4:15 pm
Humacyte Inc. HUMA Sebelius Kathleen
Director
50,000 $1.32 $66,000 91,207
(Direct)
View
2024-09-10
Sale
2024-09-11
5:53 pm
Humacyte Inc. HUMA Sebelius Kathleen
Director
5,182 $5.404 $28,004 51,207
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-13
Option Award(A)
2024-12-20
4:30 pm
N/A
N/A
EXACT SCIENCES CORP EXAS Sebelius Kathleen
Director
7,672 $0 32,671
(Direct)
View
2024-09-10
Exercise
2024-09-11
5:53 pm
N/A
N/A
Humacyte Inc. HUMA Sebelius Kathleen
Director
4,521 $4.34 51,207
(Direct)
View
2024-09-10
Exercise
2024-09-11
5:53 pm
2024-08-09
2032-06-09
Humacyte Inc. HUMA Sebelius Kathleen
Director
7,000 $0 51,207
(Direct)
View
2024-09-10
Exercise
2024-09-11
5:53 pm
N/A
N/A
Humacyte Inc. HUMA Sebelius Kathleen
Director
2,479 $3.35 51,207
(Direct)
View
2024-06-13
Option Award
2024-06-17
5:30 pm
N/A
N/A
EXACT SCIENCES CORP EXAS Sebelius Kathleen
Director
6,889 $0 31,888
(Direct)
View
2024-06-14
Exercise
2024-06-17
4:15 pm
N/A
N/A
Humacyte Inc. HUMA Sebelius Kathleen
Director
39,389 $2.56 89,389
(Direct)
View
2024-06-13
Option Award
2024-06-17
4:15 pm
N/A
2034-06-13
Humacyte Inc. HUMA Sebelius Kathleen
Director
50,000 $0 89,389
(Direct)
View
2024-06-14
Exercise
2024-06-17
4:15 pm
2018-09-01
2025-09-01
Humacyte Inc. HUMA Sebelius Kathleen
Director
39,389 $0 89,389
(Direct)
View
2023-06-15
Option Award
2023-06-16
4:11 pm
N/A
2033-06-15
Humacyte Inc. HUMA Sebelius Kathleen
Director
8,500 $0 8,500
(Direct)
View
2023-06-08
Option Award
2023-06-12
4:19 pm
N/A
N/A
EXACT SCIENCES CORP EXAS Sebelius Kathleen
Director
3,599 $0 24,999
(Direct)
View
2022-06-09
Option Award
2022-06-13
5:15 pm
N/A
N/A
EXACT SCIENCES CORP EXAS Sebelius Kathleen
Director
7,523 $0 21,400
(Direct)
View
2022-06-09
Option Award
2022-06-13
4:23 pm
N/A
2032-06-09
Humacyte Inc. HUMA Sebelius Kathleen
Director
8,500 $0 8,500
(Direct)
View
2021-10-13
Option Award
2021-10-15
3:35 pm
N/A
2031-10-13
Humacyte Inc. HUMA Sebelius Kathleen
Director
8,500 $0 8,500
(Direct)
View
2021-08-26
Option Award
2021-08-27
4:11 pm
N/A
2025-09-01
Humacyte Inc. HUMA Sebelius Kathleen
Director
56,457 $0 56,457
(Direct)
View
2021-06-30
Option Award
2021-07-02
4:12 pm
N/A
N/A
EXACT SCIENCES CORP EXAS Sebelius Kathleen
Director
2,699 $0 13,877
(Direct)
View
2020-10-22
Option Award
2020-10-23
4:46 pm
N/A
N/A
EXACT SCIENCES CORP EXAS Sebelius Kathleen
Director
420 $0 11,178
(Direct)
View
2020-09-15
Option Award
2020-09-17
4:12 pm
N/A
2030-09-14
Myovant Sciences Ltd. MYOV Sebelius Kathleen
Director
21,603 $0 21,603
(Direct)
View
2020-07-23
Option Award
2020-07-24
4:34 pm
N/A
N/A
EXACT SCIENCES CORP EXAS Sebelius Kathleen
Director
2,558 $0 10,758
(Direct)
View
(A) Indicate amendment filing.